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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Is 
postoperative consumption of coffee effective in reducing postoperative ileus?” 
STUDY DESIGN: Review of three randomized controlled trials written in the English language 
and were published in 2017, 2015, and 2012.  
DATA SOURCES: Three randomized control trials were found via PubMed.  
OUTCOMES MEASURED: Time in days from the end of surgery until the first passage of stool 
recorded by patient, or time measured in hours reported by nursing staff. 
RESULTS: Dulkskas, et al. (2015) found that the time until the first bowel movement (measured 
in days) was significantly (p < 0.05) shorter in the coffee group (3.75 ± 1.53) and water groups 
(4.14 ± 1.14). Muller et al (2012) found that the time to the first postoperative bowel movement 
was significantly shorter in the coffee arm than in the water arm (p = 0.006). Finally, Gungorduk, 
et al. (2017) stated the mean time to defecation in patients who consumed coffee postoperatively 
vs the control group was significantly reduced (43.1±9.4 vs 58.5±17.0 hours; P<.001).  
CONCLUSION: Postoperative consumption of coffee is a well-tolerated and cheap method of 
therapy to prevent and reduce the likelihood of prolonged postoperative ileus. All three studies 
demonstrate that coffee consumption after intraperitoneal surgery significantly (p<0.05) reduced 
time to first defecation after surgery compared to the control group that consumed only water 
postoperatively.  
KEY WORDS: Coffee, ileus 
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INTRODUCTION 
Postoperative ileus (POI) is a phenomenon that commonly affects patients and their 
gastrointestinal tract following surgery. It refers to a disruption in the normal peristalsis and 
motor activity of the bowel resulting in obstipation and intolerance of oral intake. This disruption 
is thought to be due to a number of etiologies including inflammatory, hormonal and 
pharmacologic influences. Inflammation is the result of direct manipulation of the bowel in 
surgery causing an immune response leading to a decrease in bowel motility. The hormonal 
aspect of ileus is due to a response from trauma that is mediated by corticotropin-releasing 
hormone.2 Pharmacologic management of pain postoperatively includes the use of opioids which 
in turn has an inhibitory effect via stimulation of µ-opioid receptors that are present in the 
bowel.2 This multifactorial etiology of POI causes symptoms such as abdominal distention, 
bloating, diffuse persistent abdominal pain, nausea, vomiting, inability to pass flatus, and 
inability to tolerate an oral diet.1 
The incidence of POI in the US is common. When patients have an intraperitoneal 
operation, it is a likely complication that they face. In an observational study of 17,000 patients 
that underwent a colectomy, POI occurred in 17.4%.1 Additionally, in a study of 27,560 patients 
undergoing elective colon resection during 2012 to 2013, POI occurred in 12.7%.1 Ileus not only 
has a clinical impact on the patients undergoing surgery, but also an economic impact on US 
healthcare system. It has been estimated to account for $750 million US dollars per year.3 Muller 
et al. reports hospital stay is 3 days longer for patients with POI, leading to increased costs of the 
US of $4000-9000 per stay.3 While there is no cure of POI, effective preventative measures play 
an important role in the efforts to reduce healthcare costs and improve patients’ recovery.  
There are few data from designed trials to guide therapy to help decrease the incidence of 
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POI. Once POI is established, scarce therapies are truly effective. Supportive care is the current 
treatment of choice for this patient population, which includes bowel rest, bowel decompression, 
and TPN. With that said, there is emphasis on the prevention of ileus. Methods of prevention 
include the replacement of postoperative opioid pain management with intraoperative methods 
like midthoracic epidural anesthesia, or transverse abdominis plane block.4 Peripheral acting µ-
opioid receptor antagonists can be used to reverse the effects of opioid induced ileus or 
constipation. Antagonists approved by the FDA for this treatment are alvimopan and 
methylnaltrexone.4 Another effective form of prevention of ileus is gum-chewing. It is known 
that chewing gum stimulates intestinal motility by activating the cephalic vagal reflex which 
increases production of gastrointestinal hormones that are associated with bowel motility.3 
Unfortunately, these mentioned treatments have not gained acceptance in clinical practice. 
Coffee differs from pharmacologic treatment for POI being that it is a common beverage 
consumed by many Americans. There is limited evidence regarding its effects on the GI system, 
but it is thought to be due to various physiochemical properties. With that said, in a study of 
healthy volunteers, authors found an increase in colonic motor activity 4 minutes after the 
ingestion of coffee using multiport manometry.3 Although the mechanism is unclear, this 
supported the hypothesis that drinking coffee after surgery may help stimulate bowel movement 
and prevent or reduce the effects of the common condition of POI.  
With limited options known to be effective in the treatment of POI, it is important that 
more studies are conducted on affordable, accessible and tolerable methods of prevention. The 
mechanisms of which coffee has an effect on bowel motility is unknown. It was thought to be 
caffeine, although studies show that decaffeinated coffee also has effects on peristalsis. Coffee is 
viewed as a prospective option for preventing POI and promoting early activation of gut motility.  
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OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Is 
postoperative consumption of coffee effective in reducing postoperative ileus in adults?” 
METHODS 
The studies chosen in this selective evidence based medicine review include 3 
randomized controlled trials. More specifically, there was a multicenter parallel open-label 
randomized clinical trial, a single-center prospective randomized clinical trial, and a randomized 
controlled trial. The population evaluated were male and female postoperative patients greater 
than or equal to 18 years of age. The intervention used was 100 mL of caffeinated coffee 3 times 
daily starting the morning after surgery. The comparisons made consisted of the treatment group 
that was given coffee and the control group that was given water. The outcome measured in each 
study was time to defecation, differing in whether or not it was measured in days vs hours, and 
whether it was patient reported or reported by nursing staff.  
The key words “coffee” and “postoperative ileus” were used to search the studies in 
PubMed and Cochrane Library. The articles were chosen based on their relevance to the clinical 
question mentioned above. In addition to that, each study was required to have patient oriented 
outcomes (POEMs). All articles were published in the English language and are peer reviewed. 
Inclusion criteria required the articles to be randomized controlled trials. Exclusion criteria 
included patients whom did not have intraperitoneal surgery. The summary of statistics reported 
were explained by p values and the change in the mean from the baseline.  
Table 1 – Demographics & Characteristics of Included Studies  
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Study Type #Pts Age 
(yrs) 
Inclusion Criteria Exclusion 
Criteria 
W/D Interventions 
Muller3 
(2012) 
Multicenter 
parallel open-
label 
randomized 
clinical trial  
 
80 >18 
yo  
Adult patients 
(aged at least 18 
years) scheduled 
for elective open 
or laparoscopic 
colonic resection 
for malignant or 
benign diseases 
 
rectal resection 
intended, stoma 
required, multi-
visceral 
resection 
planned, coffee 
allergy, 
expected lack of 
compliance, no 
surgery done, 
impaired mental 
state  
 
23 100 mL coffee 
3x daily 
Dulkskas6 
(2015) 
single-center, 
prospective, 
randomized 
clinical trial 
96 >18 
yo 
Patients >18 
years of age who 
were scheduled 
for elective 
laparoscopic left-
sided colonic 
resection for 
malignant 
diseases 
(distal to and 
including the 
splenic flexure of 
the colon) 
 
stoma required, 
multi-visceral 
resection 
planned, coffee 
allergy, 
expected lack of 
compliance, no 
surgery done, 
impaired mental 
state  
 
9 100 mL coffee 
3x daily 
Gungorduk9 
(2017) 
Randomized 
controlled 
trial  
 
118 >18 
yo 
Female patients 
who had received 
a diagnosis of 
cervical, 
endometrial, or 
ovarian cancer 
and scheduled for 
comprehensive 
staging surgery 
(hysterectomy 
and systematic 
PPL)  
 
Coffee allergy, 
thyroid disease, 
compromised 
liver function, 
arrhythmia, 
constipation, 
PMH bowel 
surgery, 
previous 
abdominal 
XRT/chemo, 
post-op ICU, 
post-op NGT, 
bowel 
anastomosis, 
use of upper 
abdominal 
multivisceral 
surgical 
approach for 
debulking 
surgery  
 
4 100 mL coffee 
3x daily 
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OUTCOMES MEASURED 
 The outcomes measured in the selected trials were based on POEMs that evaluated the 
effects of coffee consumption and time to defecation after surgery.  
In Muller et al. and Dulskas et al., both had primary endpoints as the time to defecation 
reported by nursing staff. Muller et al. measured their outcome in hours, and Dulskas et al. 
measured in days. Secondary endpoints included time to tolerance of solid food, and time to first 
passing of flatus. For the purpose of this review, the primary endpoint was the one analyzed.  
In Gungorduk et al., the primary outcome measured was time to first flatus after surgery 
and the secondary outcomes were the time to defecation and time to tolerate a solid diet. For the 
purposes of this review, the secondary outcome of time to defecation in hours was used for 
comparison. Patients were instructed to report immediately after first occurrence of flatus, bowel 
movement, or defecation. The signs and symptoms of ileus were evaluated 3 times daily and 
bowel sounds were checked 6 times daily.  
RESULTS  
 In this review, consumption of coffee and the effects on postoperative ileus are analyzed 
in 3 randomized controlled trials. The settings of all 3 studies were inpatient hospital setting with 
adults > 18 years of age whom underwent intraperitoneal surgery. Each study compared time to 
first bowel movement after consumption of water (the control group) vs consumption of coffee 
(experimental group). 
 Muller et al.3 is a multicenter open-label randomized clinical trial that selected patients 
scheduled for elective open or laparoscopic colectomy with benign or malignant disease. They 
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selected a total of 80 patients prior to surgery and assigned them to a group that was either the 
control arm that consumed water (100 ml three times daily) or the treatment group that 
consumed coffee (100 ml three times daily). Eighty patients were placed on a list with an 
allocation ratio of 1:1, and were randomized via SAS version 9.1 software without stratification 
by centre. Patients on the day of surgery were informed of their treatment assignment. It was 
impossible to blind the patient and the physician from the assignment therefore objective 
measures were obtained. The primary endpoint of time to first bowel movement was analyzed on 
an intention-to-treat basis (ITT). In the ITT analysis, only 1 patient was excluded in the control 
arm due to intraoperative change to bypass surgery. None were excluded in the coffee arm. 
Furthermore, in a per-protocol (PP) analysis, 5 patients in the control arm were excluded due to 
intraoperative change to bypass (n=1), and non-compliance (n=4). Noncompliance in the water 
arm was measured by off protocol coffee consumption. In the PP analysis of the coffee arm, 5 
were excluded due to refusal of coffee (n=2), partial refusal of coffee (n=2) and an allocation 
error (n=1). The outcome measured to determine if coffee reduced time of postoperative ileus 
was time (in hours) until first bowel movement after surgery. The continuous data were 
presented as means (s.d.) and were assessed via t-test and ANOVA as appropriate. The time to 
first bowel movement was significantly shorter in the coffee arm compared to the water arm in 
both the ITT and PP analyses. In the ITT analysis, p=0.006 with an absolute difference of 13.6 
hours (95% CI of 4.0-23.2). In the PP analysis, p=0.028 with an absolutely difference of 11.6 
hours (95% CI of 1.3-21.9). Refer to Table 2. Consumption was well accepted by the patients, 
and no adverse effects were noted.  
 Dulkas et al.6 is a prospective, single-center, randomized controlled study that evaluated 
whether or not consumption of 100 mL of coffee postoperatively is effective in preventing or 
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reducing ileus. They selected their patient population by randomizing 105 patients aged 18 or 
older that were scheduled for elective laparoscopic left sided colectomy at the National Cancer 
Institute between January 2013 and December 2014. This patient population was also divided 
into two arms: those who received coffee or water. Patients were allocated to their groups by 
using the envelope method. It was impossible to blind the patients or physicians, so the data 
collected was objective. Fifteen patients were excluded due to either not meeting the inclusion 
criteria, a change occurred in the surgical procedure, and 6 refused to participate. The data was 
expressed as mean change from the baseline. The time until first bowel movement was 
significantly (p<0.05) reduced in the decaffeinated coffee group (3.00±1.50) vs coffee with 
caffeine (3.75±1.53) vs the water group (4.14±1.15). Refer to Table 2.  
 Gungorduk et al. is a randomized controlled trial of 114 female patients >18 years of age 
that were scheduled for TAH-BSO with systematic pelvic and paraaortic lymphadenectomy. The 
patients were randomized and allocated based on envelope randomization with use of a 
computer-generated code. In total, 118 were enrolled, but due to exclusion, 114 patients were 
available for ITT analysis. One group consisting of 58 patients that consumed coffee 
postoperatively (100 mL 3 times daily), and another consisting of 56 patients that did not 
consume coffee. Complete blinding was not possible. The data collected was continuous, and a t 
test was used to compared the variables. The time to first defecation was significantly shorter 
(p<0.001) in the coffee group (42.0±6.8 hours) vs the control group (59.8±14.6 hours). Refer to 
Table 2. Coffee was well tolerated and no adverse events were observed in the context of coffee 
consumption. 
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Table 2: Outcome data displaying time to first bowel movement from Muller et al.3, 
Gungorduk et al.9 and Dulkas et al.6 
Study Water Coffee with 
caffeine 
Absolute 
Difference 
p value 
Muller, et al. (ITT 
analysis) 
74 (21.6) hrs 60.4 (21.3) hrs 13.6 (4.0-23.2) 
hrs 
0.006 
Muller et al. (PP 
analysis) 
73.7 (22.0) hrs 62.1 (21.5) hrs 11.6 (1.3-21.9) 
hrs 
0.028 
Dulkas et al. 4.14±1.15 days 3.75±1.53 days 0.39 days <0.05 
Gungorduk et al. 59.8±14.6 hrs 42.0±6.8 hrs 17.8 hrs <0.001 
Values are means (standard deviation) and in parenthesis are 95% confidence intervals 
DISCUSSION   
 Coffee is a popular drink and the effects on organ systems are well known. Such as, the 
cardiovascular system, central nervous system, and even skeletal muscle. According to Dirks-
Naylor, “Coffee has been shown to induce autophagy, improve insulin sensitivity, stimulate 
glucose uptake, slow the progression of sarcopenia, and promote the regeneration of injured 
muscle,”.7 Coffee also reduces the risk of alcoholic cirrhosis, colorectal and endometrial cancer, 
the incidence of gout, and Parkinson’s disease.8  
 On the contrary, coffee may also have detrimental effects. Caffeine in coffee can raise 
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blood pressure of individuals, which is why it is significant to note that Dulsksas et al. studied 
the effects of caffeinated coffee vs decaffeinated coffee. His study demonstrated that 
decaffeinated coffee contributed to even less time to first defecation compared to caffeinated. 
See results section. Coffee can also increase heart rate, dehydrate patients, and cause anxiety. It 
is the role of the provider to cater to the specific needs of their patient, and to decide if 
administering coffee as part of the post op regimen is more beneficial than harmful. 
 All three studies had limitations that could have affected their outcomes measured. 
Although it was desired, blinding was not feasible in any of these clinical scenarios which leaves 
room for bias. Muller et al. and Dulskas et al. both assumed sample sizes, and their calculations 
were reported to be arbitrary. This was due to lack of available previous studies to rely on. 
Muller, et al. had heterogeneity of patient population, although randomization and results of the 
multivariable and subgroup analyses make it unlikely. In Muller, et al. patients in the control arm 
had free access to coffee, which provided the opportunity for failed compliance. Factors in 
Limitations reported in Gungorduk, et al. include question on the best type of coffee to use and 
the optimal amount of coffee are unknown.  
CONCLUSION 
The three RTCs mentioned in this review demonstrate that postoperative coffee 
consumption is an effective therapy for reduction of time to first bowel movement after an 
intraperitoneal operation.  All three studies obtained a p value of <0.05, supporting a statistically 
significant hypothesis. According to Gungorduk, et al. “patients who drank coffee after surgery 
were less likely to have POPI (21.6% vs 64.9%; P<0.001)”.9 POI increases hospital stay, patient 
dissatisfaction, and expenses. It is proven and understood that postoperative coffee consumption 
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contributes to reduced time to first bowel movement after surgery, so therefore it should become 
a part of the postop regimen. Currently it is not included, and patients are being given tea, juice 
or water. In conclusion, coffee is a safe and inexpensive way to prevent POI.  
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